NEW YORK, Feb. 22, 2025 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Novo Nordisk A/S (NYSE: NVO) between November 2, 2022 and December 19, 2024, both […]
Tag: P. A.
RCAT Investor News: Rosen Law Firm Encourages Red Cat Holdings, Inc. Investors to Inquire About Securities Class Action Investigation
NEW YORK, Feb. 22, 2025 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Red Cat Holdings, Inc. (NASDAQ: RCAT) resulting from […]
PCRX Investors Have Opportunity to Lead Pacira BioSciences, Inc. Securities Fraud Lawsuit
NEW YORK, Feb. 22, 2025 /PRNewswire/ — Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Pacira BioSciences, Inc. (NASDAQ: PCRX) between August 2, 2023 and August 8, 2024, both dates […]
EPIX Investors Have Opportunity to Lead ESSA Pharma Inc. Securities Fraud Lawsuit
NEW YORK, Feb. 22, 2025 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ESSA Pharma Inc. (NASDAQ: EPIX) between December 12, 2023 and October 31, 2024, both […]
PPTA Investor News: Rosen Law Firm Encourages Perpetua Resources Corp. Investors to Inquire About Securities Class Action Investigation
NEW YORK, Feb. 22, 2025 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Perpetua Resources Corp. (NASDAQ: PPTA) resulting from […]
